Potential of pre-interventional magnetic resonance angiography for optimization of workflow and clinical outcome of prostatic arterial embolization

Abstract

PurposeImpact of pre-interventional magnetic resonance angiography (MRA) on prostatic artery embolization (PAE) regarding workflow, radiation dose, and clinical outcome. MethodRetrospective evaluation of 259 patients (mean age 68 ± 9, range 41–92) with benign prostatic hypertrophy (BPH) undergoing PAE between January 2017 and December 2020. MRA was performed in 137 cases. In 122 patients, no pre-interventional MRA was performed. Origin of the PA, volumetry of the prostatic gland and ADC values were evaluated. International Prostate Symptom Score (IPSS), Quality of Life (QoL) and International Index of Erectile Function (IIEF) were evaluated before and after PAE. ResultsOrigin of the PA was identified in all cases. Significant differences regarding volume reduction (−20 ± 13 ml with MRA vs −17 ± 9 ml without MRA) and ADC value reduction were found (−78 ± 111 10−6 mm2/s with MRA vs −45 ± 99 10−6 mm2/s without MRA). PAE workflow was modified in 16 patients due to MRA findings. Radiation dose (5518.54 ± 6677.97 µGym2 with MRA vs 23963.50 ± 19792.25 µGym2 without MRA) and fluoroscopy times (19.35 ± 9.01 min. with MRA vs 27.45 ± 12.54 min. without MRA) significantly differed. IPSS reduction improved (−11 ± 8 points with MRA vs −7 ± 9 points without MRA, p < 0.001), while QOL (−2 ± 1 points with MRA and −2 ± 2 points without MRA) and IIEF (+2 ± 10 points with MRA and +1 ± 11 points without MRA) showed no significant differences (p > 0.05). ConclusionsPre-interventional MRA facilitates improved workflow and patient safety of PAE while reducing radiation dose and intervention time.